GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.
Published May 1, 2013 · Recall initiated: April 19, 2013
Summary
FDA records drug Class II recall D-298-2013, published May 1, 2013 and initiated April 19, 2013. Recalling firm: Qualitest Pharmaceuticals; Status: Terminated; Reported quantity: 10,373 bottles; Lot: Lot #: C0671212A, Exp 12/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Qualitest Pharmaceuticals
- Distributor
- Nationwide
- Lot
- Lot #: C0671212A, Exp 12/14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAALLOPURINOL TABLETS, USP, 300 mg, 500 count bottle, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS,September 9, 2015
- FDAHydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDCJuly 22, 2015
- FDADisulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qualitest PharmaceuticalsJuly 8, 2015
- FDAPROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml contains: Codeine Phosphate 10 mg, Promethazine HydrochlorideApril 15, 2015
- FDAPropofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only,May 1, 2013
- FDAPentrexcilina (acetaminophen, chlorpheniramine maleate, and phenylephrine HCl) tablets, 20-count tablets perMay 1, 2013
Questions about this recall
Was GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21. recalled?
Yes. FDA published recall D-298-2013 on May 1, 2013. Reported hazard: Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
What should I do if I have this product?
Voluntary: Firm initiated · Letter